09 June 2026
09 June 2026
The Stealth AXiS system is designed to assist surgeons in navigating both basic and complex sinus and skull base anatomies.
Participants who finish the initial stage continue their regimen; placebo recipients are re-randomised to two COYA 302 dosing regimens.
Hympavzi is approved for routine prophylaxis to prevent bleeding episodes in US patients six years and above.
Findings from the STRIVE study indicated improved glycaemic control with Omnipod 6 compared to Omnipod 5.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
